Edition:
India

People: Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

1,929JPY
19 Apr 2019
Change (% chg)

¥7 (+0.36%)
Prev Close
¥1,922
Open
¥1,936
Day's High
¥1,937
Day's Low
¥1,918
Volume
67,300
Avg. Vol
114,382
52-wk High
¥2,677
52-wk Low
¥1,790

Kato, Hiroki 

Mr. Hiroki Kato has been serving as Director of Pharmaceutical Sales and Director in Zeria Pharmaceutical Co., Ltd. since February 5, 2019. He joined the Company in April 1988. His previous titles include Director of Medical Development, Director of 3rd Clinical Development and Director of 1st Clinical Development in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --